These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 834976)

  • 1. Criteria for selection of patients for medical treatment (chenodeoxycholic acid therapy) of gallstones.
    Bruusgaard A; Malver E; Pedersen LR; Schlichting P; Sylvest J
    Scand J Gastroenterol; 1977; 12(1):97-102. PubMed ID: 834976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications for medical dissolution of biliary lithiasis and value of the determination of the lithogenic index].
    Vuaridel D; Borel GA; Bron B
    Schweiz Med Wochenschr; 1980 May; 110(22):877-9. PubMed ID: 7403822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
    Iser JH; Dowling H; Mok HY; Bell GD
    N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biochemistry of gallstone formation.
    Bouchier IA
    Clin Gastroenterol; 1973 Jan; 2(1):49-66. PubMed ID: 4271976
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.
    Salen G; Colalillo A; Verga D; Bagan E; Tint GS; Shefer S
    Gastroenterology; 1980 Jun; 78(6):1412-8. PubMed ID: 7372061
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicity of chenodeoxycholic acid in the rhesus monkey.
    Dyrszka H; Chen T; Salen G; Mosbach EH
    Gastroenterology; 1975 Aug; 69(2):333-7. PubMed ID: 1150041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesophase formation during cholesterol gallstone dissolution in human bile: effect of bile acid composition.
    Su CC; Higuchi WI; Gilmore IT; Danzinger RG; Hofmann AF
    J Pharm Sci; 1984 Aug; 73(8):1160-1. PubMed ID: 6491925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholelitholysis--gallbladder sediments and pigment stones].
    Wolpers C; Wosiewitz U
    Leber Magen Darm; 1985 Mar; 15(2):64-70. PubMed ID: 3990499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of biliary cholesterol, phospholipids and bile acid compositions and the development of cholesterol cholelithiasis in mice].
    Yamahara J; Chisaka T; Sawada T; Fujimura H
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):171-80. PubMed ID: 6662416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
    Ahlberg J; Angelin B; Einarsson K
    J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
    Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
    Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in biliary bile acid composition and cholesterol saturation of bile in patients with cholesterol gallstones following treatment with ursodeoxycholic acid].
    Stiehl A; Czygan P; Fröhling W; Kommerell B
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():501-2. PubMed ID: 612017
    [No Abstract]   [Full Text] [Related]  

  • 20. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
    Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM
    Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.